Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab for IVIG-resistant Kawasaki disease
jRCT1091220086Completed
- Sponsor
- Investigator-initiated Clinical Research (in-house)
- Start
- Apr 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of infliximab in Kawasaki disease (KD), sponsored by Investigator-initiated Clinical Research (in-house). Primary endpoint: Coronary artery aneurysm after infliximab injection. Started Apr 2012; status: completed.
02
Drugs
infliximab
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on jRCT1091220086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220086.